elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q54118869-174E4EAE-137E-4843-AB1E-724F61CB5188
Q54118869-174E4EAE-137E-4843-AB1E-724F61CB5188
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54118869-174E4EAE-137E-4843-AB1E-724F61CB5188
Targeting MDMX and PKCδ to improve current uveal melanoma therapeutic strategies.
P2860
Q54118869-174E4EAE-137E-4843-AB1E-724F61CB5188
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54118869-174E4EAE-137E-4843-AB1E-724F61CB5188
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8edcce4ea98f0b68320f4570fbe27bf043310dc6
P2860
Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors